We focus on treating the whole person, addressing underlying conditions like hypertension or type 2 diabetes while utilizing advanced GLP-1 therapies to help you regain control over your appetite and your life
The ability to avoid needles, and to eat and drink without restrictions, should make this new GLP-1 pill an appealing option to some patients who cant take the injected GLP-1 drugs, says Marilyn Tan, MD, a clinical associate professor and endocrinologist at the Stanford University School of Medicine in California
This $99 add-on test helps your provider create a more personalized long-term plan
2-9 They do this by: Building confidence and self-efficacy by empowering patients to actively engage with their treatment journey Educating patients to address the widespread misconception that obesity is not a disease, with 40% of patients unaware of this and 80% feeling solely responsible for their condition Implementing a whole-health approach to redefine treatment success, focus on overall health outcomes, not just weight loss Setting realistic expectations which prepares patients for the possibility of losing less weight than expected while still achieving significant health benefits Supporting medication adherence by providing tools for reminders, routines, titration guidance, and addressing injection anxiety Driving medication persistence as a result of setting realistic expectations and frame treatment around long-term health gains rather than short-term weight loss Mitigating side effects through equipping patients to self-manage common side effects through proactive tracking and helping them connect the dots Want to learn even more about how digital solutions can unlock the full potential of GLP-1 therapies
Distribution channels include Hospitals, Retail Pharmacies, and Online Pharmacies, with Retail Pharmacies valued at 10.0 to 32.0 USD Billion
